Rui Wang
Shandong University of Traditional Chinese Medicine(CN)China Pharmaceutical University(CN)Anhui Medical University(CN)Chinese PLA General Hospital(CN)Jiangsu Nhwa Pharmaceutical (China)(CN)Michigan Center for Translational Pathology(US)First Affiliated Hospital of Xi'an Jiaotong University(CN)Changchun University of Chinese Medicine(CN)Quotient Clinical (United Kingdom)(GB)Second Hospital of Tianjin Medical University(CN)Henan Agricultural University(CN)Tianjin Medical University(CN)China Medical University(CN)
Publications by Year
Research Areas
RNA modifications and cancer, Cancer-related molecular mechanisms research, Bioactive natural compounds, Cancer-related gene regulation, Lung Cancer Treatments and Mutations
Most-Cited Works
- → Cellular senescence and cancer: Focusing on traditional Chinese medicine and natural products(2020)238 cited
- → Candidate Biomarkers and Molecular Mechanism Investigation for Glioblastoma Multiforme Utilizing WGCNA(2018)119 cited
- → A PRC2-independent function for EZH2 in regulating rRNA 2′-O methylation and IRES-dependent translation(2021)102 cited
- → M6A associated TSUC7 inhibition contributed to Erlotinib resistance in lung adenocarcinoma through a notch signaling activation dependent way(2021)90 cited
- → Enhancement of TKI sensitivity in lung adenocarcinoma through m6A-dependent translational repression of Wnt signaling by circ-FBXW7(2023)82 cited
- → A Randomized Pilot Study of Atractylenolide I on Gastric Cancer Cachexia Patients(2007)75 cited